|10th December 2018
Healthcare markets are becoming more competitive and complex. The sheer number of products coming off patent in the next five years, coupled with the growing healthcare spend and the number of players entering the healthcare space, mean it's clear pharma launches are becoming more challenging.
Adding to the pressure is the evolving networks of stakeholders who each have a differing needs and pain points and often communicate using novel digital channels.
However, while the market can seem overwhelming, these challenges provide pharma organisations with an opportunity to meet the unmet needs of customers through clearer and more targeted marketing, and more streamlined launches.
This in-depth report was created in collaboration with Pharma Intelligence and is based on our significant experience in this area. It features interviews with senior leaders and primary market research, as well as giving key recommendations for achieving launch success in challenging markets.
|27th March 2020
Senior Associate Consultant, Manos Mastorakis, takes a look at a number of COVID-19 drugs that are already registered in clinical trials, providing analysis aiming to simplify the current landscape.
|6th March 2020
BLH speaks to MM patient advocate, Peter McCleave, to find out how he has fought to remain positive throughout his treatment journey while simultaneously leading a successful campaign to get more people to sign up to be a blood stem cell donor.
|28th February 2020
Pharmaceutical and healthcare companies invest a great deal of time and money in commissioning research to address their insight gaps. The process often results in suboptimal return on investment (ROI) due to faulty communication and inefficient documentation of insights. Amit Sheinholtz, Senior Associate User Experience Consultant and Elisa del Galdo, Head of Customer Experience discuss common pitfalls of the negative insight lifecycle and how to avoid them.